The importance of intracranial atherosclerotic disease (ICAD) as a cause of stroke is
underscored as compared to that of extracranial carotid stenosis and nonvalvular atrial …

Background Early results of the Stenting and Aggressive Medical Management for
Preventing Recurrent stroke in Intracranial Stenosis trial showed that, by 30 days, 33 (14 …

Intracranial atherosclerotic disease (ICAD) causes up to 10% of all ischemic strokes, and the
rate of recurrent vascular ischemic events is very high. Important predictors of vulnerability in …

BACKGROUND AND PURPOSE: There are limited studies on the morphologic
characteristics of MCA atherosclerotic stenosis. Our aim was to quantitatively assess the …

Background and purpose To investigate the relationship between physician and site
experience and the risk of 30 day hemorrhagic and ischemic strokes in the stenting arm of …

Background Intracranial artery stenosis (ICAS) is an arterial narrowing in the brain that can
cause stroke. Endovascular therapy (ET) and conventional medical treatment (CMT) may …

Introduction. The initial promise of endovascular stenting for the treatment of intracranial
atherosclerotic disease (ICAD) has been tempered by the results of the SAMMPRIS trial …

Background In-stent restenosis (ISR) is an adverse and notable event in the treatment of
intracranial atherosclerotic stenosis (ICAS) with percutaneous transluminal angioplasty and …

Significant advances in our understanding of transient ischemic attack (TIA) have taken
place since it was first recognized as a major risk factor for stroke during the late 1950's …

Background: Atherosclerotic stenosis of the major intracranial arteries is the most common
cause of ischemic stroke. There are limited treatments for severe intracranial stenosis, and …